Literature DB >> 19249946

Agents for the decolonization of methicillin-resistant Staphylococcus aureus.

Kevin W McConeghy1, Dennis J Mikolich, Kerry L LaPlante.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are a common cause of hospital- and community-acquired infections. Persons may have asymptomatic colonization with MRSA in the nares, axillae, perineum, or groin. Since MRSA colonization often precedes infection, and infection is associated with significant morbidity and mortality, there is great interest in preventing the transmission of MRSA and decolonizing persons who harbor these bacteria. We provide an evidence-based review of MRSA decolonization agents. Our search strategy included the databases of the Cochrane Central Register of Controlled Trials, MEDLINE (1962-May 2008), and EMBASE (1980-May 2008). To identify unpublished trials, abstract books from appropriate major scientific meetings were hand searched, manufacturers were contacted, and pharmacology references were researched for available commercial products, formulations, adverse events, and dosing. The most extensive research in MRSA decolonization has been conducted with mupirocin, which is applied to the anterior nares 2-3 times/day for 5 days. Increased use is correlated to resistance development; therefore, routine decolonization is not prudent unless MRSA colonization is confirmed in the nares or other site. Retapamulin is under investigation for use in nares decolonization. If total body decolonization is necessary, bathing or showering with an antiseptic agent such as chlorhexidine gluconate is recommended in combination with mupirocin applied to the nares to improve the likelihood of eradication. Oral antibiotics have been evaluated for use in decolonization of the skin and nares but should be considered only in conjunction with topical agents and when all other decolonization attempts and environmental controls have been exhausted. Homeopathic and investigational agents may also be effective. Although mupirocin is the standard of care for decolonization of MRSA, several agents demonstrate efficacy and many merit further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249946     DOI: 10.1592/phco.29.3.263

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  24 in total

1.  The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; Becky Tsui; G Jonathan Lewis; Robert R Muder; Lee H Harrison; Lee M Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

Review 2.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

Review 3.  Antimicrobial Resistance to Agents Used for Staphylococcus aureus Decolonization: Is There a Reason for Concern?

Authors:  Gregory R Madden; Costi D Sifri
Journal:  Curr Infect Dis Rep       Date:  2018-06-07       Impact factor: 3.725

Review 4.  Antibiotic prophylaxis in craniotomy: a review.

Authors:  Weiming Liu; Ming Ni; Yuewei Zhang; Rob J M Groen
Journal:  Neurosurg Rev       Date:  2014-02-13       Impact factor: 3.042

5.  Methicillin-resistant Staphylococcus aureus (MRSA) nasal real-time PCR: a predictive tool for contamination of the hospital environment.

Authors:  Daniel J Livorsi; David J Livorsi; Sana Arif; Patricia Garry; Madan G Kundu; Sarah W Satola; Thomas H Davis; Byron Batteiger; Amy B Kressel
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01       Impact factor: 3.254

6.  Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.

Authors:  F Jacobsen; C Fisahn; M Sorkin; I Thiele; T Hirsch; I Stricker; T Klaassen; A Roemer; B Fugmann; L Steinstraesser
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

7.  Use of Corynebacterium pseudodiphtheriticum for elimination of Staphylococcus aureus from the nasal cavity in volunteers exposed to abnormal microclimate and altered gaseous environment.

Authors:  N V Kiryukhina; V G Melnikov; A V Suvorov; Yu A Morozova; V K Ilyin
Journal:  Probiotics Antimicrob Proteins       Date:  2013-12       Impact factor: 4.609

8.  Does the nose know? An update on MRSA decolonization strategies.

Authors:  C L Abad; M S Pulia; N Safdar
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

9.  The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients.

Authors:  Yeohan Song; Julie H Y Tai; Sarah M Bartsch; Richard K Zimmerman; Robert R Muder; Bruce Y Lee
Journal:  Vaccine       Date:  2012-03-29       Impact factor: 3.641

10.  Antimicrobial photodynamic activity of gallium-substituted haemoglobin on silver nanoparticles.

Authors:  Ana V Morales-de-Echegaray; Lu Lin; Badhu Sivasubramaniam; Aiganym Yermembetova; Qi Wang; Nader S Abutaleb; Mohamed N Seleem; Alexander Wei
Journal:  Nanoscale       Date:  2020-11-05       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.